Skip to main content
Livermore
Livermore
ZHEN

HighTower Advisors, LLC

SEC CIK
0001462245
Latest filing
Aug 25, 2026

ALLO holding history

Allogene Therapeutics, Inc. in every 13F filed by HighTower Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ALLO overviewAll 13F holders of ALLOFull Q2 2026 holdings

Shares (Q2 2026)
0
Sold out in Q2 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of ALLO by HighTower Advisors, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20260$00.0%−13,441−100.0%Sold outHolders
Q1 202613,441$32.8K<0.1%+13,441NewHolders
Q4 20250$00.0%−11,740−100.0%Sold outHolders
Q3 202511,740$14.6K<0.1%−410−3.4%ReducedHolders
Q2 202512,150$13.7K<0.1%00.0%UnchangedHolders
Q1 202512,150$17.7K<0.1%00.0%UnchangedHolders
Q4 202412,150$25.9K<0.1%−17,500−59.0%ReducedHolders
Q3 202429,650$82.0K<0.1%−906−3.0%ReducedHolders
Q2 202430,556$72.0K<0.1%00.0%UnchangedHolders
Q1 202430,556$137.0K<0.1%+5,000+19.6%AddedHolders
Q4 202325,556$82.0K<0.1%−30,303−54.2%ReducedHolders
Q3 202355,859$176.0K<0.1%−468−0.8%ReducedHolders
Q2 202356,327$279.0K<0.1%−532−0.9%ReducedHolders
Q1 202356,859$280.0K<0.1%−488−0.9%ReducedHolders
Q4 202257,347$361.0K<0.1%−10,712−15.7%ReducedHolders
Q3 202268,059$734.0K<0.1%00.0%UnchangedHolders
Q2 202268,059$776.0K<0.1%+17,500+34.6%AddedHolders
Q1 202250,559$462.0K<0.1%−30−0.1%ReducedHolders
Q4 202150,589$753.0K<0.1%−1,220−2.4%ReducedHolders
Q3 202151,809$1.33M<0.1%+5,500+11.9%AddedHolders
Q2 202146,309$1.21M<0.1%−2,000−4.1%ReducedHolders
Q1 202148,309$1.70M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.